Mirum Pharmaceuticals (MIRM) Amortizatization of Intangibles (2019 - 2023)
Mirum Pharmaceuticals (MIRM) posted quarterly Amortizatization of Intangibles of $29000.0 for Q4 2023, down 97.15% year-over-year from $1.0 million in Q4 2022, and down 87.61% quarter-over-quarter from $234000.0 in Q3 2023.
Powered by 
Analysis
Mirum Pharmaceuticals (MIRM) Amortizatization of Intangibles (2019 - 2023) Analysis & Trends
Mirum Pharmaceuticals' Amortizatization of Intangibles history runs 5 years deep, the most recent figure standing at $29000.0 for Q4 2023.
- In Q4 2023, Amortizatization of Intangibles fell 97.15% year-over-year to $29000.0; the TTM figure through Dec 2023 stood at $1.7 million (up 1.29% YoY), while the FY2023 annual figure was $1.7 million, up 1.29% from the prior year.
- Amortizatization of Intangibles for Q4 2023 stood at $29000.0, down from $234000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $1.0 million in Q4 2022, with the low at -$45000.0 in Q2 2020.
- The 5-year median for Amortizatization of Intangibles is $58000.0 (2021), against an average of $208578.9.
- The sharpest annual moves came in 2020 and 2023: Amortizatization of Intangibles plunged 228.57% in 2020, then surged 1742.22% in 2023.
- Mirum Pharmaceuticals' Amortizatization of Intangibles stood at $127000.0 in 2019, then dropped by 18.11% to $104000.0 in 2020, then plunged by 45.19% to $57000.0 in 2021, then soared by 1684.21% to $1.0 million in 2022, then sank by 97.15% to $29000.0 in 2023.
- Business Quant data shows MIRM's Amortizatization of Intangibles at $29000.0 in Q4 2023, $234000.0 in Q3 2023, and $633000.0 in Q2 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 4.33 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 678,000.00 |
| 10 | Mirum Pharmaceuticals | 6.40 Bn | 5.96 Bn | 145.90 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 29,000.00 |
| Sep 30, 2023 | 234,000.00 |
| Jun 30, 2023 | 633,000.00 |
| Mar 31, 2023 | 829,000.00 |
| Dec 31, 2022 | 1.02 Mn |
| Sep 30, 2022 | 583,000.00 |
| Jun 30, 2022 | 2,000.00 |
| Mar 31, 2022 | 101,000.00 |
| Dec 31, 2021 | -148,000.00 |
| Sep 30, 2021 | 94,000.00 |
| Jun 30, 2021 | 96,000.00 |
| Mar 31, 2021 | 95,000.00 |
| Dec 31, 2020 | 104,000.00 |
| Sep 30, 2020 | -39,000.00 |
| Jun 30, 2020 | -45,000.00 |
| Mar 31, 2020 | 52,000.00 |
| Dec 31, 2019 | 127,000.00 |
| Sep 30, 2019 | 164,000.00 |
| Jun 30, 2019 | 35,000.00 |